tri-luma

Do you have darkened spots on your cheeks and forehead? It may be melasma.

The good news is there's hope for a brighter tomorrow.

Tri-Luma Cream is the only triple-action cream approved for the short-term and intermittent long-term treatment of moderate to severe melasma. The latest long-term safety studies confirm that Tri-Luma Cream is safe and effective when used for longer than eight weeks and repeatedly thereafter when melasma recurs.

Tri-Luma's special combination of three active ingredients is more effective than any combination of the individual components in reducing the darkened skin caused by melasma

Tri-Luma Cream is contraindicated in individuals with a hypersensitivity, allergy or intolerance to fluocinolone acetonide, hydroquinone or tretinoin. In clinical trials, the most frequently reported side effects were erythema, desquamation, burning, dryness and pruritus.

Mild to moderate redness, peeling, burning, dryness or itching may be experienced. This product contains sulfites that may cause severe allergic reactions including anaphylactic symptoms and life-threatening asthma attacks. Exposure to sunlight, sunlamps or UV light and extreme heat, wind or cold should be avoided. Use of sunscreen with appropriate SPF of 30 or higher is required. Wear protective clothing and change to nonhormonal forms of birth control, if hormonal methods are used.

Tri-Luma Cream contains hydroquinone, which may produce exogenous ochronosis, a gradual blue-black darkening of the skin, whose occurrence should prompt discontinuation of therapy. Tri-Luma Cream contains the corticosteroid fluocinolone acetonide. Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression with the potential for corticosteroid insufficiency after withdrawal of treatment.

Tri-Luma Cream (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) is the only triple-action cream for the short-term and intermittent long-term treatment of moderate to severe melasma of the face.

Tri-Luma Cream can help reduce or eliminate the discoloration caused by melasma. In fact, the combination of the three active ingredients in Tri-Luma Cream is more effective than any combination of the individual components. Women treated with Tri-Luma Cream also reported a favorable side effect profile as compared to women using various combinations of the ingredients.

Tri-Luma Cream has been clinically proven - in three studies - to improve and frequently clear melasma after eight weeks of treatment. If melasma has not cleared in eight weeks, the latest long-term safety studies confirm that Tri-Luma Cream is safe to use until melasma is resolved. It is also safe to use again whenever the condition reappears. Because melasma can be worsened by sun exposure, long-term therapy should include sun protection.

Women who are pregnant, plan to become pregnant or are nursing should wait to begin treatment with Tri-Luma Cream until after pregnancy or when nursing has concluded. The safety and efficacy of Tri-Luma Cream in pregnant women and nursing mothers have not been established.